CzilliT.TanJ.KnezevicS.PetersC. Cost of medications recommended by Canadian acne clinical practice guidelines. J Cutan Med Surg. 2016;20(6):542-545.doi:10.1177/1203475416653735
2.
TanJ.KnezevicS.BoyalS.WatermanB.JanikT. Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150 mg/kg. J Cutan Med Surg. 2016;20(1):13-20.doi:10.1177/1203475415595776
3.
AsaiY.BaibergenovaA.DutilMet al. Management of acne: Canadian clinical practice guideline. Can Med Assoc J. 2016;188(2):118-126.doi:10.1503/cmaj.140665
4.
ZaengleinAL.PathyAL.SchlosserBJet al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.doi:10.1016/j.jaad.2015.12.037
5.
BarbieriJS.ShinDB.WangS.MargolisDJ.TakeshitaJ. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2019.doi:10.1016/j.jaad.2019.06.025
6.
LeeYH.ScharnitzTP.MuscatJ.ChenA.Gupta-EleraG.KirbyJS. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(1):35-44.doi:10.1001/jamadermatol.2015.3091
7.
ÖktemA.HayranY.ArıE.YalçınB. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris. J Dermatolog Treat. 2019;16:1-5.doi:10.1080/09546634.2019.1591578
